(Q81702060)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15863132%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

title

Skin toxicity associated with pegylated liposomal doxorubicin (40 mg/m2) in the treatment of gynecologic cancers (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15863132%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

1 reference

Robert J Kim

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15863132%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Gertrude Peterson

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15863132%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Barbara Kulp

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15863132%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Kristine M Zanotti

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15863132%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Maurie Markman

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15863132%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

publication date

1 May 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15863132%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15863132%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

volume

97

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15863132%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15863132%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

page(s)

374-378

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15863132%20AND%20SRC:MED&resulttype=core&format=json

Cyclophosphamide plus cisplatin versus cyclophosphamide, doxorubicin, and cisplatin chemotherapy of ovarian carcinoma: a meta-analysis. The Ovarian Cancer Meta-Analysis Project

11 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.12.057

Impact of doxorubicin on survival in advanced ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.12.057

Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.12.057

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.12.057

Liposomal doxorubicin: antitumor activity and unique toxicities during two complementary phase I studies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.12.057

Lack of vesicant injury following extravasation of liposomal doxorubicin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.12.057

Sterically stabilized liposomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.12.057

Phase II study of liposomal doxorubicin in refractory ovarian cancer: antitumor activity and toxicity modification by liposomal encapsulation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.12.057

Skin toxic effects of polyethylene glycol-coated liposomal doxorubicin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.12.057

Phase 2 trial of liposomal doxorubicin (40 mg/m(2)) in platinum/paclitaxel-refractory ovarian and fallopian tube cancers and primary carcinoma of the peritoneum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.12.057

The clinical utility of liposomal doxorubicin in recurrent ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.12.057

Phase 2 trial of pegylated liposomal doxorubicin in advanced endometrial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.12.057

The use of cardiac biopsy to demonstrate reduced cardiotoxicity in AIDS Kaposi's sarcoma patients treated with pegylated liposomal doxorubicin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.12.057

The cutaneous histopathology of chemotherapeutic reactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.12.057

Phase I and pharmacologic study of intermittent twice-daily oral therapy with capecitabine in patients with advanced and/or metastatic cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.12.057

Phase II trial of the pegylated liposomal doxorubicin in previously treated metastatic endometrial cancer: a Gynecologic Oncology Group study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.12.057

Phase II study of liposomal doxorubicin in platinum- and paclitaxel-refractory epithelial ovarian cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.12.057

Recurrent epithelial ovarian carcinoma: a randomized phase III study of pegylated liposomal doxorubicin versus topotecan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.12.057

Liposomal doxorubicin in ovarian, peritoneal, and tubal carcinoma: a retrospective comparative study of single-agent dosages.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.12.057

Prostaglandins protect against murine hair injury produced by ionizing radiation or doxorubicin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.12.057

Topical DMSO treatment for pegylated liposomal doxorubicin-induced palmar-plantar erythrodysesthesia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.12.057

Cardiac safety profile of prolonged (>or=6 cycles) pegylated liposomal doxorubicin administration in patients with gynecologic malignancies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.12.057

10.1016/J.YGYNO.2004.12.057

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15863132%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

1 reference